Treatment of Post-Tonsillectomy Hemorrhage With Nebulized Tranexamic Acid: Initial Investigation of a Novel Therapeutic Modality
Annals of Otology, Rhinology & Laryngology · 2024-08 · 133 (8) · 729-734
DOI: 10.1177/00034894241254697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, online erschienen am 27.05.2024. Verfasst von Matthew Maksimoski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Northwestern University, Chicago, IL, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Tonsillectomy, Nebulizers and Vaporizers, Postoperative Hemorrhage. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objectives
The use of nebulized tranexamic acid (TXA) in massive pulmonary hemorrhage is well-described. Published utilization in post-tonsillectomy bleeding (PTB) is limited to a single case. This study examines whether TXA resulted in change of operative intervention necessity and narcotic utilization.
Methods
This was a retrospective cohort study at a single, urban academic medical center in the United States. Chart review was conducted of all patients who presented to the hospital for post-tonsillectomy bleed (PTB) between 3/1/2018 and 7/1/2020. Demographic data, intervention modality, need for control under general anesthesia, and opioid use were collected and analyzed.
Results
Twenty-one patients underwent a total of 23 visits for PTB over the study period. Control of hemorrhage without need for operating room intervention for PTB was 100% (6/6) for patients receiving TXA nebulizer and 53% (9/17) for those receiving other treatment modalities. Opioid usage in hospital and on discharge was also lower in patients receiving TXA nebulizers. All results were statistically significant.
Conclusions
Our study supports nebulized TXA as an effective, non-invasive mode of hemostasis in patients presenting to the emergency department for post-tonsillectomy hemorrhage. Nebulized TXA may prevent the need for general anesthesia and operative intervention. Otolaryngologists should consider addition of this novel treatment appropriation of TXA to their management options for postoperative tonsillar hemorrhage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Northwestern University, Chicago, IL, USA.
- Department of Emergency Medicine, Northwestern University, Chicago, IL, USA.
ORCID-Profile: Matthew Maksimoski
Zitieren
APA
Maksimoski, M., McCauley, M., Osoba, M., Pirotte, M., & Liddy, W. (2024). Treatment of Post-Tonsillectomy Hemorrhage With Nebulized Tranexamic Acid: Initial Investigation of a Novel Therapeutic Modality. Annals of Otology, Rhinology & Laryngology, 133(8), 729-734. https://doi.org/10.1177/00034894241254697
Vancouver
Maksimoski M, McCauley M, Osoba M, Pirotte M, Liddy W. Treatment of Post-Tonsillectomy Hemorrhage With Nebulized Tranexamic Acid: Initial Investigation of a Novel Therapeutic Modality. Annals of Otology, Rhinology & Laryngology. 2024;133(8):729-734. doi:10.1177/00034894241254697
BibTeX
@article{Maksimoski2024,
author = {Maksimoski, Matthew and McCauley, Matthew and Osoba, Muyinat and Pirotte, Matthew and Liddy, Whitney},
title = {Treatment of Post-Tonsillectomy Hemorrhage With Nebulized Tranexamic Acid: Initial Investigation of a Novel Therapeutic Modality},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2024},
volume = {133},
number = {8},
pages = {729--734},
doi = {10.1177/00034894241254697}
}
EUVIMED